Proceedings of the second Artificial Intelligence in Primary Immunodeficiency (AIPI) meeting
Journal of Allergy and Clinical Immunology · 2026-02 · 157 (2) · 307-315
DOI: 10.1016/j.jaci.2025.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-02. Verfasst von Jacques G Rivière und 42 weiteren Autor:innen. Beteiligte Einrichtung: Universitat Autònoma de Barcelona, Barcelona, Spain; Infection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca, …. Hauptthemen laut MEDLINE: Artificial Intelligence, Primary Immunodeficiency Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The use of artificial intelligence (AI) in inborn errors of immunity offers transformative potential in diagnostics and disease management but faces multiple challenges that were discussed at the second Artificial Intelligence in Primary Immunodeficiency conference, held in New York City (March 19-22, 2025). The conference addressed 7 themes: predictive diagnostic algorithms, health equity, industry collaboration, advanced computational tools like large language models, patient-led AI initiatives, multiomics integration, and implementation science. Discussions highlighted the growing impact of AI on diagnostics, genomics, and health systems, emphasizing the need for high-quality, diverse datasets and ethical safeguards to ensure equitable application. Participants stressed that AI alone cannot resolve systemic inequities or delays in diagnosis. Challenges such as the lack of harmonized datasets, the complexity of integrating multiomics data, ethical concerns, and the difficulty of adapting solutions to low-resource settings were emphasized. Additionally, the use implementation science was pointed out as one of the major challenges to ensure applicability and scalability in real-world settings. This requires overcoming resistance to adoption, addressing infrastructure gaps, and ensuring regulatory compliance. Collaboration across academia, clinicians, patients, regulators, and industry is essential to ensure AI delivers equitable, lasting benefits for individuals with inborn errors of immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universitat Autònoma de Barcelona, Barcelona, Spain; Infection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca, Barcelona, Spain; Pediatric Infectious Diseases and Immunodeficiencies…
- Vanderbilt University Medical Center, Nashville, Tenn.
- University College London Institute of Immunity and Transplantation, London, United Kingdom.
- Catalan Health Service, Barcelona, Spain; Digitalization for the Sustainability of the Healthcare System (DS3) Research Group, Barcelona, Spain.
- Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, University of California, Los Angeles, Calif.
- School of Global Public Health and the Tandon School of Engineering, New York University, New York, NY.
Förderung
- NIAID NIH HHS
Zitieren
APA
Rivière, J. G., Bastarache, L., Campos, L. C., Carot-Sans, G., Chin, A., Chunara, R., Cunningham-Rundles, C., Erra, L., Farmer, J., Garcelon, N., Hsieh, E., Leavis, H., Lee, S., Liu, L., Kusters, M., Lloyd, B. C., Martinson, A. K., Mester, R., Moore, J. B., …, & Rider, N. L. (2026). Proceedings of the second Artificial Intelligence in Primary Immunodeficiency (AIPI) meeting. Journal of Allergy and Clinical Immunology, 157(2), 307-315. https://doi.org/10.1016/j.jaci.2025.09.002
Vancouver
Rivière JG, Bastarache L, Campos LC, Carot-Sans G, Chin A, Chunara R, et al. Proceedings of the second Artificial Intelligence in Primary Immunodeficiency (AIPI) meeting. Journal of Allergy and Clinical Immunology. 2026;157(2):307-315. doi:10.1016/j.jaci.2025.09.002
BibTeX
@article{Rivire2026,
author = {Rivière, Jacques G and Bastarache, Lisa and Campos, Luiza C and Carot-Sans, Gerard and Chin, Aaron and Chunara, Rumi and Cunningham-Rundles, Charlotte and Erra, Lorenzo and Farmer, Jocelyn and Garcelon, Nicolas and Hsieh, Elena and Leavis, Helen and Lee, Seungwon and Liu, Liangying and Kusters, Maaike and Lloyd, Brian C and Martinson, Alexandra K and Mester, Rachel and Moore, Justin B and Moshous, Despina and Orange, Jordan S and Parrish, Nefatia and Parker, Sarah Henrickson and Pasaniuc, Bogdan and Peng, Xiao P and Pergent, Martine and Piera-Jiménez, Jordi and Quinn, Jessica and Ramesh, Sidharth and Roberts, Kirk and Robinson, Peter N and Savova, Guergana and Scalchunes, Christopher and Seidel, Markus G and Simoneau, Rachel and Soler-Palacin, Pere and Sullivan, Kathleen E and Van Gijn, Marielle and Wi, Chung-Il and Zhou, Dawei and Tenembaum, Vanessa and Butte, Manish J and Rider, Nicholas L},
title = {Proceedings of the second Artificial Intelligence in Primary Immunodeficiency (AIPI) meeting},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
volume = {157},
number = {2},
pages = {307--315},
doi = {10.1016/j.jaci.2025.09.002}
}
EUVIMED